ARTICLES BY THIS AUTHOR
- 4/18/2021
CVS Pharmacy, Walgreens and Walmart now selling Abbott’s at-home COVID-19 test OTC
Three leading chains are adding an OTC at-home COVID-19 test to their offerings. - 4/18/2021
NAB's Smith touts pharmacy's trusted role to Senate subcommittee
In describing insights from the National Association of Broadcasters' partnership with the Reynolds Journey Institute, NAB's Gordon Smith highlighted findings that underscored local pharmacies as trusted community messengers. - 4/18/2021
GoodRx acquires HealthiNation
HealthiNation offers video content that will provide a new avenue for pharmaceutical manufacturers to reach target audiences via GoodRx. - 4/18/2021
Kinney Drugs partners with law enforcement for National DEA Prescription Drug Take-Back Day
Kinney Drugs will host several events at its New York and Vermont stores on Saturday, April 24th from 10 a.m. to 2 p.m. - 4/18/2021
FDA approves new indication for ALK's Ragwitek
Ragwitek now is indicated to treat ragweed pollen allergy in children and adolescents 5-17 years old, in addition to adults as old as 65. - 4/15/2021
FDA clears Nextstellis from Mayne, Mithra
Nextstellis is the first and only contraceptive pill containing estetrol, a native estrogen, which is produced from a plant source. It is also the first new estrogen to hit the U.S. market in more than 50 years, the company said. - 4/15/2021
FDA clears Opdivo as first-line gastric cancer treatment
Opdivo is the first FDA-approved immunotherapy for the first-line treatment of gastric cancer. - 4/15/2021
Nexus intros generic Quelicin
Generic Quelicin is a sterile, nonpyrogenic solution that is used as an ultra-short-acting, depolarizing, skeletal muscle relaxant. - 4/14/2021
NCPA survey highlights how independents are vaccinating underserved groups
Almost half of the respondents in a survey conducted by the National Community Pharmacists Association said they were serving populations with a significant minority population, and nearly 80% operate in places with fewer than 50,000 people. - 4/14/2021
Lannett submits ANDA for generic Advair Diskus
Advair Diskus has a market value of approximately $3 billion for the 12 months ended February 2021, although actual generic market values are expected to be lower.